Skip to main content

CCTG Connection



Published:
Category: Group updates
CCTG Annual Spring Meeting of Participants May 3 - 5 - meeting in progress

The CCTG Annual Spring Meeting of Participants will be held Friday, May 3 to Sunday, May 5 at the Chelsea Hotel in Toronto. Here are some updates if you are planning on joining us.

Meeting Invitations

If you are planning meetings and/or attending the Spring Meeting be sure to read your Invitation carefully so you are clear on the funding support associated with your Invitation.

Read More



Published:
Category: Group updates
2024-2025 CCTG Practicum application deadline is almost here

The deadline is approaching to submit applications for the 2024-2025 CCTG Practicum. 

Read More

Published:
Category: Group updates
CCTG is recruiting for a Patient Representative to support the Genitourinary Committee

The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Genitourinary Disease Site Committee. CCTG is an inclusive organization dedicated to building a diverse network. This is a volunteer role for membership on the Gynecology Disease Site Committee, the Gynecology Disease Site Executive Committee, and the CCTG Patient Representative Committee.

Read More

Published:
Category: Group updates
CCTG Recognition Awards - Call for Nominations
The Canadian Cancer Trials Group is seeking nominations for the 2024 Recognition Awards honouring individuals who have contributed significantly to the mission and activities of the Group. Read More

Published:
Category: Group updates
EDIIA Virtual Round Table: March 5

Please join CCTG on March 5 from 1:30 to 3:00 pm EST for a virtual roundtable on integrating equity, diversity, and inclusion in cancer clinical trials. We look forward to welcoming Dr. Doreen Ezeife, Dr. Carmen Guerra, and Dr. Tina Hsu to lead us in this conversation which will be moderated by CCTG Senior Investigator Dr. Wendy Parulekar. 

Read More

Published:
Category: Group updates
 ID.me important update
IMPORTANT UPDATE NCI has partnered with ID.me to incorporate required identity verification (IP) and multifactor authentication (MFA) into CTEP systems access. These security features previously required two elements: Read More

Published:
Category: Group updates
CCTG is recruiting for a Patient Representative to support the Gynecology Committee

The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Gynecology Disease Site Committee. CCTG is an inclusive organization dedicated to building a diverse network. This is a volunteer role for membership on the Gynecology Disease Site Committee, the Gynecology Disease Site Executive Committee, and the CCTG Patient Representative Committee.

Read More

Published:
Category: Trials
A new multiple myeloma trial assessing the duration of treatment injections has opened in Canada

The CCTG MY13 trial is a phase III non-inferiority randomized controlled trial of fixed duration versus continuous daratumumab among transplant in eligible older adults with newly diagnosed multiple myeloma.

There is little scientific evidence around the effective timing of injectable treatments for multiple myeloma. These patients receive treatment with three medicines - two tablets and an injection - all continued indefinitely until they stop working, or the side effects become unmanageable. 

Read More